Katsuji Aikawa

566 total citations
13 papers, 488 citations indexed

About

Katsuji Aikawa is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Katsuji Aikawa has authored 13 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Infectious Diseases and 4 papers in Virology. Recurrent topics in Katsuji Aikawa's work include HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and Hormonal and reproductive studies (3 papers). Katsuji Aikawa is often cited by papers focused on HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and Hormonal and reproductive studies (3 papers). Katsuji Aikawa collaborates with scholars based in Japan, United States and France. Katsuji Aikawa's co-authors include Naoyuki Kanzaki, Mitsuru Shiraishi, Yoshio Aramaki, Masanori Baba, Yuji Iizawa, Masaki Seto, Naoki Miyamoto, Toshi Nagata, Takahito Hara and Masuo Yamaoka and has published in prestigious journals such as Journal of Medicinal Chemistry, Inorganic Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Katsuji Aikawa

13 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katsuji Aikawa Japan	11	257	159	91	46	43	13	488
Michael A. Stier United States	15	378 1.5×	377 2.4×	50 0.5×	13 0.3×	50 1.2×	37	719
Yoshihiko Odagaki Japan	14	332 1.3×	226 1.4×	93 1.0×	16 0.3×	47 1.1×	28	563
Scot Campbell United States	15	412 1.6×	256 1.6×	155 1.7×	34 0.7×	85 2.0×	28	648
Valério Berdini United Kingdom	13	292 1.1×	564 3.5×	98 1.1×	20 0.4×	56 1.3×	22	899
Xicai Huang Canada	11	252 1.0×	183 1.2×	22 0.2×	14 0.3×	35 0.8×	18	373
André Alker Switzerland	14	364 1.4×	243 1.5×	27 0.3×	33 0.7×	38 0.9×	31	695
Sharon Boggs United States	11	202 0.8×	232 1.5×	146 1.6×	23 0.5×	35 0.8×	12	513
Luc J. Farmer United States	14	227 0.9×	160 1.0×	60 0.7×	133 2.9×	20 0.5×	25	602
Tony Raynham United Kingdom	20	554 2.2×	410 2.6×	71 0.8×	23 0.5×	44 1.0×	34	866
Paul‐James Jones United States	10	162 0.6×	205 1.3×	32 0.4×	8 0.2×	48 1.1×	19	495

Countries citing papers authored by Katsuji Aikawa

Since Specialization

Citations

This map shows the geographic impact of Katsuji Aikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katsuji Aikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katsuji Aikawa more than expected).

Fields of papers citing papers by Katsuji Aikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katsuji Aikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katsuji Aikawa. The network helps show where Katsuji Aikawa may publish in the future.

Co-authorship network of co-authors of Katsuji Aikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Katsuji Aikawa. A scholar is included among the top collaborators of Katsuji Aikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katsuji Aikawa. Katsuji Aikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Tsumura, Ryo, Yoshikatsu Koga, Akinobu Hamada, et al.. (2020). Report of the use of patient‐derived xenograft models in the development of anticancer drugs in Japan. Cancer Science. 111(9). 3386–3394. 11 indexed citations

Aikawa, Katsuji, Koji Ono, Noriyuki Habuka, et al.. (2017). Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs) Part III: Discovery of 4-(5-oxopyrrolidine-1-yl)benzonitrile derivative 2f as a clinical candidate. Bioorganic & Medicinal Chemistry. 25(13). 3330–3349. 36 indexed citations

Morimoto, Megumi, Katsuji Aikawa, Takahito Hara, & Masuo Yamaoka. (2017). Prevention of body weight loss and sarcopenia by a novel selective androgen receptor modulator in cancer cachexia models. Oncology Letters. 14(6). 8066–8071. 27 indexed citations

Aikawa, Katsuji, Takenori Hitaka, Yumi Imai, et al.. (2015). Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I. Bioorganic & Medicinal Chemistry. 23(10). 2568–2578. 19 indexed citations

Sameshima, Tomoya, Ikuo Miyahisa, Misaki Homma, et al.. (2014). A simple and widely applicable hit validation strategy for protein–protein interaction inhibitors based on a quantitative ligand displacement assay. Bioorganic & Medicinal Chemistry Letters. 24(24). 5836–5839. 2 indexed citations

Tanaka, Yuta, Katsuji Aikawa, Goushi Nishida, et al.. (2013). Discovery of Potent Mcl-1/Bcl-xL Dual Inhibitors by Using a Hybridization Strategy Based on Structural Analysis of Target Proteins. Journal of Medicinal Chemistry. 56(23). 9635–9645. 91 indexed citations

Yamamoto, Satoshi, Hiromi Kobayashi, Tomohiro Kaku, et al.. (2012). Design, synthesis, and biological evaluation of 3-aryl-3-hydroxy-1-phenylpyrrolidine derivatives as novel androgen receptor antagonists. Bioorganic & Medicinal Chemistry. 21(1). 70–83. 9 indexed citations

Seto, Masaki, Katsuji Aikawa, Naoki Miyamoto, et al.. (2006). Highly Potent and Orally Active CCR5 Antagonists as Anti-HIV-1 Agents: Synthesis and Biological Activities of 1-Benzazocine Derivatives Containing a Sulfoxide Moiety. Journal of Medicinal Chemistry. 49(6). 2037–2048. 75 indexed citations

Seto, Masaki, Naoki Miyamoto, Katsuji Aikawa, et al.. (2004). Orally active CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological activities of 1-benzazepine derivatives containing a sulfoxide moiety. Bioorganic & Medicinal Chemistry. 13(2). 363–386. 82 indexed citations

10.

Seto, Masaki, Yoshio Aramaki, Tomohiro Okawa, et al.. (2004). Orally Active CCR5 Antagonists as Anti-HIV-1 Agents: Synthesis and Biological Activity of 1-Benzothiepine 1,1-Dioxide and 1-Benzazepine Derivatives Containing a Tertiary Amine Moiety. Chemical and Pharmaceutical Bulletin. 52(5). 577–590. 49 indexed citations

11.

Wada, Tohru, et al.. (2004). A Platinum−Ruthenium Dinuclear Complex Bridged by Bis(terpyridyl)xanthene. Inorganic Chemistry. 43(22). 7210–7217. 45 indexed citations

12.

Seto, Masaki, Yoshio Aramaki, Hiroshi Imoto, et al.. (2004). Orally Active CCR5 Antagonists as Anti-HIV-1 Agents 2: Synthesis and Biological Activities of Anilide Derivatives Containing a Pyridine N-Oxide Moiety. Chemical and Pharmaceutical Bulletin. 52(7). 818–829. 31 indexed citations

13.

Aikawa, Katsuji & Toshi Nagata. (2000). Synthesis of a dinucleating ligand xanthene-bis(tris(2-pyridylmethyl)amine) and its manganese complex. Inorganica Chimica Acta. 306(2). 223–226. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact